Glial cells are a large component of the developing nervous system, appearing before the onset of axon outgrowth in a variety of developing systems. Their time of appearance and their location in conjunction with developing axon pathways may allow them to define the position of axon pathways. Specific glial cells may be utilized as guideposts by growing axons, allowing them to recognize the appropriate pathway, or conversely, glial cells may inhibit axons from growing along an inappropriate pathway. The 7F7 monoclonal antibody labels a subset of glial cells in grasshopper embryos that may play a role in defining the location of selected axonal pathways. This antibody recognizes the REGA- 1 molecule, a cell-surface antigen with a molecular weight of 60 kDa, which is regionally expressed on developing glial cells. REGA-1 is expressed around the edges of clusters of glial cells and on lamellae extending from glial cells to line the edges of some axonal pathways. REGA-1 expression is first seen in the neuroblast sheet, surrounding neuroblast 4–1. Slightly later in development, 2 glial cells extend processes that express REGA-1 and demarcate the caudal edge of the anterior commissure. As the animal matures, cell processes expressing REGA-1 line the edges of the longitudinal connective, then expand to surround the central neuropil of the segmental ganglia. REGA-1 expression is also seen in conjunction with axons leaving the segmental ganglia via the segmental nerves and the intersegmental connectives. REGA-1 expression is limited to a subset of glial cells; some known glial cells such as the segment boundary cell do not express REGA-1. Glial cell processes expressing REGA-1 are seen only in association with axons, which suggests that these processes may act as borders or guard rails confining axons to the appropriate regions of the developing CNS. Axons navigating a path through the CNS may be prohibited from growing into inappropriate regions based on their inability to cross the boundaries established by glial cells expressing REGA-1.